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Aims. Maternal mental distress in pregnancy can be damaging to the mother and child’s physical and mental 
health. This study aimed to provide insight into mental wellbeing of pregnant women in Denmark  during 
COVID-19, by assessing symptoms of depression and anxiety.  
Methods. Data from two cohorts of pregnant women recruited from Danish general practice were compared. 
A COVID-19 lockdown cohort (n=330) completed questionnaires between April 8th and May 6th. 
Responses were compared to those from a control cohort of women from 2016 (n=1428). Mental wellbeing 
was measured with the Major Depression Inventory (MDI) and the Anxiety Symptom Scale (ASS). 
Results. Questionnaires were returned by 83% of the COVID-19 lockdown cohort and by 93% of the control 
cohort. A multivariable analysis controlling for age, cohabitation status, occupation, smoking, alcohol use, 
chronic disease, fertility treatment, parity and children living at home showed no difference in depressive 
symptoms (MDI). Anxiety symptoms (ASS) were slightly worse in the COVID-19 lockdown cohort (mean 
difference 1.4 points), mainly driven by questions concerning general anxiety. The largest differences in 
anxiety were seen in first trimester (adjusted mean difference: 4.0 points).  
Conclusion. Pregnant women questioned during COVID-19 showed no change in symptoms of depression 
and only a modest elevation of anxiety when compared to pregnant women questioned during a non-
pandemic period in 2016.  
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As the coronavirus pandemic sweeps across the world, it may induce fear and stress. Added to the fear of 
contracting the virus are the significant changes to our daily lives, as quarantine and social distancing 
measures are implemented to slow down the spread of the virus. Worrying about family and friends being 
infected may also be a burden. It is, therefore, not surprising that reviews of early studies of mental health in 
the pandemic have revealed lower psychological well-being and higher scores of depression and anxiety in 





Studies on COVID-19 and adverse pregnancy consequences have been published recently, mostly 
investigating respiratory-related outcomes in the pregnant woman and the neonate. The impact of the 
pandemic on maternal mental health has received less attention 
3
. Mental distress during pregnancy, 
however, is a major public health concern. Stressful events are associated with adverse outcomes for the 
mother as well as the child; possible negative effects include premature delivery 
4
, disrupted mother-child 
attachment 
5, 6
, and adverse developmental outcomes in the child, including increased risk of emotional and 
behavioural problems,
7, 8, 9
. A single study comparing mental health in pregnant women before and during 
COVID-19 has shown increased levels of distress during COVID-19
10
, which raises concern. 
 
Aims 
Our study aimed to provide insight into the mental wellbeing of pregnant women’s in Denmark  during 
COVID-19 by assessing symptoms of depression and anxiety. 
Methods 
The study compared depression and anxiety symptoms in a sample of pregnant women during COVID-19 






, 2020, the World Health Organisation (WHO) declared COVID-19 a global pandemic with 
110,000 confirmed cases of virus infection in 110 countries. The previous day, Denmark had 157 confirmed 
cases and on March 11
th
 the government announced that this number had increased to 514 and responded 
with a lockdown from the 12
th
 of March. Schools and daycare centers were closed; employees in the public 
sector were sent home and only people working in critical functions maintained a physical presence at work. 
The government also urged Danish private-sector employers to ask their employees to work from home. 
Danish employment insurance funds reported an increase of 39% in unemployment in early May, despite a 
late March agreement on a temporary salary compensation to protect private companies and their employees. 
The social life of the population was affected too; sports, leisure activities, cinemas, etc. were locked down, 
while gatherings of more than 10 people were prohibited, and large shops and malls were closed. Danish 
authorities encouraged social distancing but never instituted a curfew or mandated face masks as seen in 
some other countries. A gradual re-opening began in mid-April, starting with daycare, schools and the 
private labour market.  
Danish National Health Services regarded preventive antenatal programmes as high priority, and preventive 
consultations were not paused during lockdown 
11
. The preventive health services in general practice and 
midwifery adapted to the situation by re-structuring some of the appointments to video consultations. At the 
same time, fathers/partners were not allowed to join e.g. ultrasound examinations. 
 
Participants 
This study compared the mental wellbeing of two groups of pregnant women; one group which was pregnant 
before lockdown (in 2016) and one group which was pregnant during lockdown in 2020. The participating 
pregnant women in both groups had been recruited by general practitioners (GPs) in Capital Region and 
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Region Zealand (two of the five administrative regions in Denmark) at the first preventive antenatal 
consultation occurring around 10 weeks’ gestation. None of the groups received interventions for depression 
or anxiety. The preventive antenatal consultation is free of charge and almost all pregnant women attend. 
The participating general practitioners were asked to consecutively include all Danish-speaking pregnant 
women. Women who participated gave informed consent to provide data from the pregnancy record and 
questionnaires. Women were excluded if they withdrew consent or if the pregnancy ended in abortion or 
stillbirth. Details of the two cohorts are given below. 
The COVID-19 lockdown cohort included pregnant women enrolled in an existing cluster randomized trial of 
an online psycho-educational program.  Recruitment started in 2019 and participants who had not given birth 
by April 8
th
, 2020 were included in this study. They had given informed consent to take part in a project 
focusing on quality improvement of preventive mother-child consultations in general practice, and on the 
mental health of small children and their families 
12
. Half of the participating general practitioners would 
inform their patients about a web-based program to increase resilience in families. All included women who 
were still pregnant on April 8
th
, 2020 - four weeks after the lockdown began - were sent a questionnaire. One 
reminder was sent after 2 weeks and all answers received before May 6
th
 were included in the study. A 
secure electronic mail system (e-Boks) was used to inform participants about the survey, and questionnaires 
were completed and returned into the study database (REDCap).  
The control cohort. A similar cohort from April 2015 was used as control, here 192 general practitioners 
included pregnant women at their first antenatal appointment 
13
. Women gave informed consent to taking 
part in a general quality improvement study. Data were obtained until August 2016 and all participating 
pregnant women were sent three questionnaires at around gestational weeks 10, 26 and 33, including 
questions about depressive symptoms (Major Depression Inventory – MDI 
14,15
) and anxiety (Anxiety 
Symptom Scale – ASS 
16
). Questionnaires were answered by means of SurveyXact and reminders were sent 




Outcomes. The Major Depression Inventory (MDI) is a self-reported instrument consisting of ten items each 
with a Likert scale ranging from 0 (“at no time”) to 5 (“all the time”), giving a range of 0-50 in the total 
score. Used as a depression severity scale the cut-off scores are 0-20 (no or doubtful depression), 21-25 (mild 
depression), 26-30 (moderate depression), and 31-50 (severe depression) 
13, 14
. 
The Anxiety Symptom Scale (ASS) screens for anxiety symptoms and can be used as an initial method to 
ascertain anxiety. ASS is a self-reported instrument and is recommended by the Danish College of General 
Practitioners 
16
. The ten ASS items include general anxiety (items 1-2), avoidance behavior (item 3), panic 
attacks (items 4-5), OCD symptoms (items 6-8) and post-traumatic anxiety (item 9). Item 10 covers level of 
functioning. Each item ranges from 0 (no anxiety symptoms) to 5 (anxiety symptoms occurring all the time) 
which gives a total ASS score with a range between 0-50 
14
. Since ASS was not primarily devised as an 
outcome measure for clinical scientific inquiry, its psychometric properties were not investigated and are as 
yet unknown. We therefore investigated the responses to the individual items in a secondary analysis. 
Covariates. Information was collected from the Pregnancy Health Record and from an electronic patient 
questionnaire. The Pregnancy Health Record is a national two-page form, which was filled by the GP and 
sent to the midwife as well as the expected place of birth. In this study the following parts of the record were 
used: Sociodemographic: Age (≤25, 26-30, 31-35, >35), Cohabitation status (single/ living with partner). 
Lifestyle habits: Smoking during pregnancy (yes/no), Alcohol during pregnancy (yes/no), Recreational drugs 
during pregnancy (yes/no). Physical health: heart disease, lung disease, thyroid disease, diabetes, epilepsy, 
psychiatric disorder (no/yes). Reproductive background: Fertility treatment (yes/no), Parity: Given birth (no/ 
yes, one/ yes, several times), Miscarriage (no/ yes, one/ yes, several times). The electronic patient 
questionnaire contained Occupational status (employed/ student/ other/ unemployed/ sick leave) and 
Children living at home (no/yes).  




Differences in the distribution of covariates between the two cohorts were assessed by chi-squared tests. The 
difference in mean outcome between the two cohorts was assessed in multivariable linear regression models. 
The women in the control were asked to fill the questionnaire each trimester, and we therefore had up to 
three per woman; 
while the women of the Covid-19 lockdown cohort completed the questionnaire only once during their 
pregnancy. The statistical analysis corrected for this excess correlation of assessments in the control group 
by including a random effect in the mixed linear model. The differences were adjusted only for trimester 
(unadjusted), or adjusted additionally for age, cohabitation status, occupation, smoking, alcohol- and drug 
use, fertility treatment, previous abortions and children living at home. Additionally, in subgroup analyses 
the cohort effect was assessed in similar fashion for the categories of a selection of covariates. Statistical 
significance was set at 1%. Calculations were performed in SAS v9.4.     
 
Ethics 
Women included in both cohorts gave written consent for researchers to access data from their Pregnancy 
Health Record and to allow questionnaires about mental well-being to be sent. 
Results 
ASS and MDI were sent to 330 pregnant women in 2020 during COVID-19 lockdown. The COVID-19 
lockdown cohort comprised 33 women in the first trimester of pregnancy (weeks 0-12), 219 in the second 
trimester and 78 in the third trimester .Two hundred and fifty three (83%) were completed. ASS and MDI 
were sent to 1428 pregnant women in 2016 and were completed by 1428 in the first trimester (100%), by 
1343 women in the second trimester (94%) and by 1326 women (93%) in the third trimester. 
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Table I shows the characteristics of the women in the two cohorts. The only statistically significant 
difference between the groups was related to the number of previous births, but the fraction that had not 
given birth previously was almost the same in the two groups (45% in the control group versus 43% in the 
Covid-19 lockdown group). 
Table II and III show MDI and ASS scores for the pregnant women during COVID-19 lockdown compared 
to the control group from 2016. No significant difference in MDI was observed, while ASS was somewhat 
higher during lockdown. The difference in total ASS score (1.4 points) remained statistically significant after 
adjusting for potential confounding. The difference in anxiety symptoms varied across trimesters; the largest 
difference was seen in the first trimester (4 points), followed by the third trimester with a difference of 2 
points. Subgroup analyses did not show significant differences in MDI or ASS between categories of 
selected covariates.    
Table IV shows the results for the individual ASS items. We observed higher levels of general anxiety (items 
1 and 2) and avoidance behavior (item 3) but lower social phobia (item 8) in the COVID-19 lockdown 
cohort, while for the other items no substantial difference was observed.  
Discussion 
We found no changes in depressive symptoms among pregnant women during the early phase of COVID-19 
lockdown in the Danish society. The level of anxiety was higher during lockdown with an average difference 
between the two cohorts of 1.4 point on a scale from 0 to 50.  
Our unique opportunity to compare data from two similar cohorts of women made it possible to assess the 
association between antenatal mental health and the lockdown. It is, however, important to consider the ways 
in which these two cohorts may be different apart from the pandemic. Secular trends may themselves 
produce changes, but the period (4 years) is relatively short, and we are not aware of any major changes in 
the situation of pregnant women in Denmark over these years apart from the lockdown. The sampling of the 
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women for the two groups was in many ways similar. They were recruited into the two cohorts by their 
general practitioners, and the women gave informed consent to participate in a study where they would 
receive questionnaires several times during their pregnancy. The present analysis was, however, of 
convenience and sampling of the two cohorts was not designed for the present purpose. The Covid-19 
lockdown cohort comprised a relatively small group of women, which made statistical analysis less 
powerful. There was, furthermore, a difference in response rates between the two cohorts, which was due to 
the nature of the projects behind the two samples.  The 2016 control group was a dedicated cohort followed 
during pregnancy and much effort was put into collecting each questionnaire. The COVID-19 group received 
fewer reminders, because the project needs to follow the women for several years without overloading the 
participants. The use of the mixed model corrects, however, for bias through differential attrition, when this 
is related to the variables (such as sociodemographic characteristics) that are in the model. None of the 
groups received interventions aimed at symptoms of depression or anxiety but half of the women in the 
lockdown group had access to an intervention which aimed at improving psychological resilience in general. 
Any effect of this intervention may have reduced ASS in the COVID-19 lockdown cohort and decreased the 
difference compared to the control group. There have been recent preliminary reports about pregnant 
women’s mental wellbeing during the pandemic 
 17 19 20
. A Canadian study of pregnant women from May 
2020 contrasted antenatal maternal stress during COVID-19 with symptoms in a cohort of women before the 
pandemic. This study found an upsurge in both depressive and anxiety symptoms in pregnant women during 
COVID-19 
10
. A survey of mental wellbeing in pregnant women and new mothers during the pandemic 
found similar signs of increased symptoms of depression and anxiety 
21
. Similarly, a number of general 
population studies have found an increase of depressive as well as anxiety symptoms, while we only found 
enhanced anxiety symptoms in pregnant Danish women. Methodological differences may be part of the 
explanation, but national differences may also be important: The majority of published papers about mental 





; recently published studies of general population mental well-being in Denmark and 





Several explanations for the pandemic’s apparently low impact on mental wellbeing in pregnant women 
could be offered, including the fact that Denmark never faced a curfew such as that seen in some other 
countries. In addition, shops were open and people were free to move around in public as long as a safe 
distance was kept from others. Primary care and hospitals were also never overwhelmed with patients; this 
fact was repeatedly communicated by authorities through national TV with high viewing figures, reaching 
almost half of the population. Pregnant women are well protected against dismissal during pregnancy and 
can be absent with compensation; for some pregnant women the lockdown may have been an opportunity for 
more stable circumstances at home. A survey in the general population saw the psychological well-being of 
the Danish population apparently improving from early spring to the end of April 
22 24
.   
A pandemic and the subsequent societal changes during spring 2020 might be expected to impact mental 
health in pregnant women more than our results show. The virus itself may not have impacted public mental 
health substantially because the health threat rapidly turned out to be low. Any negative impact on mental 
wellbeing may very well rather come from the societal and economic consequences of locking down society. 
This could lead to economic depression in the longer term. It is, therefore, important to monitor the mental 
well-being of pregnant women for a longer period of time. Future studies should also look into how the 
pandemic and lockdown might have had differential effects on families from varying backgrounds: the two 
cohorts of pregnant women in this study represented a socioeconomically rather privileged group that could 
not be regarded as vulnerable.  
Conclusion 
COVID-19 and the lockdown led to sudden societal changes not seen in Denmark since World War II. In 
spring 2020, the crisis did not have any immediate strong effect on the mental wellbeing of pregnant women 
in Denmark when significantly elevated levels of depression and anxiety among Danish pregnant women 
during COVID-19 lockdown might have been expected. At this early point of the pandemic, pregnant 
women appeared to be only moderately more anxious compared to pregnant women during a non-COVID-19 
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Table I: Characteristics of participating women in the 2016 cohort (control) and COVID-19 lockdown cohort.  
 
Control cohort from 2016 
(n=1428) 
COVID-19 lockdown cohort 
(n=330)  
 N (%) N (%) Sign. 
Age    0.1604 
   ≤25 years 180 (12.6) 28 (8.5)  
   26-30 years 491 (34.4) 122 (37.0)  
   31-35 years 480 (33.6) 120 (36.4)  
   >35 years 277 (19.4) 60 (18.1)  
Cohabitation status   0.6188 
   Single 71 (5.0) 17 (5.7)  
   Living with partner 1357 (95.0) 283 (94.3)  
Children living at home   0.8977 
   No 590 (41.3) 123 (40.9)  
   Yes 838 (58.7) 178 (59.1)  
Occupation   0.2488 
   Employed 1069 (74.9) 242 (73.8)  
   Student 197 (13.8) 51 (15.6)  
   Other 61 (4.3) 9 (2.7)  
   Unemployed 75 (5.3) 15 (4.6)  
   Sick leave 26 (1.8) 11 (3.4)  
Smoking during pregnancy   0.0882 
   No 1331 (93.2) 288 (96.0)  
   Yes 97 (6.8) 12 (4.0)  
Alcohol during pregnancy   0.9630 
   No 1418 (99.3) 294 (99.3)  
   Yes 10 (0.7) 2 (0.7)  
Recreational drugs during pregnancy   0.2671 
   No 1424 (99.7) 287 (99.3)  
   Yes 4 (0.3) 2 (0.7)  
Chronic heart disease   0.3859 
   No 1365 (95.6) 312 (94.6)  
   Yes 63 (4.4) 18 (5.4)  
Chronic lung disease   0.3479 
   No 1328 (93.0) 302 (91.5)  
   Yes 100 (7.0) 28 (8.5)  
Thyroid disease   0.2524 
   No 1372 (96.1) 322 (97.6)  
   Yes 56 (3.9) 8 (2.4)  
Diabetes   0.7200 
   No 1418 (99.3) 327 (99.1)  
   Yes 10 (0.7) 3 (0.9)  
Epilepsy   0.2430 
   No 1414 (99.0) 324 (98.2)  
   Yes 14 (1.0) 6 (1.8)  
Psychiatric disorder   0.8128 
   No 1324 (92.7) 308 (93.3)  
   Yes 104 (7.3) 22 (6.7)  
Fertility treatment   0.8335 
   No 1288 (90.2) 284 (90.7)  
   Yes 140 (9.8) 29 (9.3)  
Given birth    0.0012 
   No 645 (45.2) 136 (43.0)  
   Yes, one  530 (37.1) 146 (46.2)  
   Yes, several 253 (17.7) 34 (10.8)  
Previous abortion   0.3945 
   No 892 (62.5) 187 (59.2)  
   Yes, one 367 (25.7) 93 (29.4)  
   Yes, several 169 (11.8) 36 (11.4)  
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Table II: Depression symptoms assessed by Major Depression Inventory (MDI-score) in the COVID-19 lockdown cohort compared to the control cohort from 2016. 
 Control cohort from 2016 COVID-19 lockdown cohort Unadjusted   Adjusted   
 Mean (SD) Mean (SD) Mean diff. (95%CI) Sign. Sign.1 Mean diff. (95%CI) Sign. Sign.1 
MDI         
 10.7 (7.6) 9.5 (7.5) -0.62 (-1.63 ; 0.38) 0.2209  -0.57 (-1.62 ; 0.48) 0.2872  
Trimester 
1st trimester 11.8 (8.1) 14.6 (8.1) 2.83 (-0.04 ; 5.71) 0.0535 0.0339 3.16 (0.26 ; 6.06) 0.0327 0.0253 
2nd trimester 10.0 (7.5) 8.6 (6.7) -1.28 (-2.51 ; -0.04) 0.0426  -1.16 (-2.50 ; 0.18) 0.0895  
3rd trimester 10.3 (7.0) 9.7 (8.3) -0.51 (-2.42 ; 1.40) 0.6011  -0.95 (-2.86 ; 0.97) 0.3318  
Chronic lung disease 
No 10.7 (7.6) 9.6 (7.6) -0.56 (-1.60 ; 0.49) 0.2981 0.6421 -0.49 (-1.58 ; 0.60) 0.3820 0.2917 
Yes 10.9 (7.6) 9.0 (5.9) -1.40 (-4.81 ; 2.01) 0.4210  -2.62 (-6.45 ; 1.20) 0.1792  
Psychiatric disorder 
No 10.3 (7.4) 9.4 (7.2) -0.38 (-1.40 ; 0.64) 0.4678 0.0966 -0.31 (-1.40 ; 0.77) 0.5708 0.0202 
Yes 15.4 (9.1) 11.0 (10.8) -3.68 (-7.44 ; 0.08) 0.0551  -5.29 (-9.34 ; -1.23) 0.0106  
Fertility treatment 
No 10.7 (7.7) 12.5 (9.2) -0.48 (-1.56 ; 0.59) 0.3775 0.1298 -0.38 (-1.49 ; 0.74) 0.5082 0.1629 
Yes 10.8 (7.0) 9.6 (7.6) -3.06 (-6.21 ; 0.10) 0.0576  -2.75 (-5.88 ; 0.39) 0.0861  
Children living at home 
No 10.8 (7.6) 9.4 (7.7) -0.78 (-2.32 ; 0.77) 0.3232 0.7589 -1.15 (-2.75 ; 0.46) 0.1607 0.4145 
Yes 10.7 (7.6) 9.7 (7.4) -0.46 (-1.80 ; 0.88) 0.5008  -0.27 (-1.65 ; 1.12) 0.7042  
Given birth 
No 10.7 (7.5) 9.4 (7.7) -0.74 (-2.24 ; 0.76) 0.3323 0.9070 -0.93 (-2.46 ; 0.60) 0.2336 0.6170 
One 10.8 (7.6) 9.3 (6.8) -0.89 (-2.42 ; 0.64) 0.2547  -0.66 (-2.25 ; 0.93) 0.4163  
Multiple 10.6 (8.0) 9.8 (9.3) -0.09 (-3.29 ; 3.11) 0.9557  0.94 (-2.47 ; 4.36) 0.5880  
Previous abortions 
No 10.3 (7.3) 9.5 (7.3) -0.18 (-1.46 ; 1.11) 0.7868 0.3411 -0.27 (-1.59 ; 1.05) 0.6911 0.4502 
One 11.3 (8.0) 9.6 (7.9) -1.32 (-3.32 ; 0.67) 0.1937  -0.75 (-2.85 ; 1.36) 0.4870  
Multiple 11.4 (8.2) 8.4 (7.2) -2.26 (-5.14 ; 0.62) 0.1234  -2.37 (-5.36 ; 0.63) 0.1215  





Table III: Anxiety symptoms assessed by Anxiety Symptom Scale (ASS-score) in the COVID-19 lockdown cohort compared to the control cohort form 2016. 
 Control cohort from 2016 COVID-19 lockdown cohort Unadjusted   Adjusted   
 Mean (SD) Mean (SD) Mean diff. (95%CI) Sign. Sign.1 Mean diff. (95%CI) Sign. Sign.1 
Trimester 
1st trimester 3.4 (4.6) 7.0 (6.1) 3.56 (1.91 ; 5.20) <.0001 0.0079 4.00 (2.37 ; 5.64) <.0001 0.0004 
2nd trimester 3.1 (4.3) 4.0 (4.3) 0.92 (0.22 ; 1.62) 0.0104  0.60 (-0.15 ; 1.36) 0.1165  
3rd trimester 2.9 (3.9) 4.9 (5.0) 1.99 (0.90 ; 3.07) 0.0003  2.05 (0.97 ; 3.13) 0.0002  
Chronic lung disease 
No 3.1 (4.3) 4.5 (4.7) 1.44 (0.84 ; 2.03) <.0001 0.6257 1.30 (0.68 ; 1.91) <.0001 0.2916 
Yes 3.2 (4.0) 5.0 (6.0) 1.93 (0.02 ; 3.85) 0.0476  2.47 (0.37 ; 4.58) 0.0213  
Psychiatric disorder 
No 2.9 (4.0) 4.4 (4.6) 1.60 (1.02 ; 2.18) <.0001 0.1607 1.53 (0.91 ; 2.14) <.0001 0.0938 
Yes 6.3 (6.2) 6.2 (6.6) 0.05 (-2.03 ; 2.14) 0.9611  -0.44 (-2.67 ; 1.78) 0.6956  
Fertility treatment 
No 3.1 (4.3) 4.6 (4.6) 1.28 (0.67 ; 1.89) <.0001 0.0519 1.18 (0.55 ; 1.81) 0.0002 0.0625 
Yes 3.2 (4.2) 6.3 (6.0) 3.14 (1.37 ; 4.92) 0.0005  2.94 (1.20 ; 4.68) 0.0009  
Children living at home 
No 3.2 (4.3) 4.7 (5.2) 1.56 (0.68 ; 2.43) 0.0005 0.7792 1.33 (0.43 ; 2.23) 0.0039 0.8710 
Yes 3.1 (4.3) 4.4 (4.5) 1.39 (0.63 ; 2.15) 0.0004  1.43 (0.65 ; 2.21) 0.0003  
Given birth 
No 3.2 (4.2) 4.8 (5.5) 1.72 (0.87 ; 2.58) <.0001 0.5114 1.57 (0.71 ; 2.43) 0.0004 0.7514 
One 3.2 (4.5) 4.5 (4.2) 1.42 (0.55 ; 2.29) 0.0014  1.29 (0.39 ; 2.19) 0.0051  
Multiple 3.0 (4.0) 3.4 (3.7) 0.54 (-1.28 ; 2.37) 0.5601  0.81 (-1.13 ; 2.74) 0.4131  
Previous abortion 
No 2.9 (4.1) 4.5 (4.7) 1.69 (0.96 ; 2.42) <.0001 0.6446 1.61 (0.86 ; 2.36) <.0001 0.6193 
One 3.6 (4.8) 4.8 (4.4) 1.26 (0.12 ; 2.40) 0.0301  1.08 (-0.11 ; 2.27) 0.0746  
Multiple 3.4 (4.1) 4.2 (6.0) 0.95 (-0.68 ; 2.57) 0.2534  0.88 (-0.78 ; 2.55) 0.2998  





Table IV: Items from the Anxiety Symptom Scale in the COVID-19 lockdown cohort compared to the control cohort from 2016 in relation to the trimester of pregnancy. 
 Control cohort from 2016 Covid-19 lockdown cohort Unadjusted   Adjusted   
 Mean (SD) Mean (SD) Mean diff. (95%CI) Sign. Sign.1 Mean diff. (95%CI) Sign. Sign.1 
A1 Nervousness, tension or inner unrest? 
 1.1 (1.1) 1.5 (1.1) 0.44 (0.30 ; 0.59) <.0001  0.44 (0.29 ; 0.60) <.0001  
1st trimester 1.3 (1.2) 2.2 (1.3) 0.96 (0.53 ; 1.39) <.0001 0.0336 1.06 (0.62 ; 1.50) <.0001 0.0082 
2nd trimester 1.0 (1.1) 1.4 (1.0) 0.35 (0.17 ; 0.53) 0.0001  0.31 (0.11 ; 0.51) 0.0026  
3rd trimester 1.1 (1.0) 1.5 (1.2) 0.45 (0.17 ; 0.73) 0.0018  0.47 (0.18 ; 0.75) 0.0014  
A2 Worrying too much about even the most insignificant things in your daily life? 
 0.7 (1.0) 1.0 (1.2) 0.25 (0.11 ; 0.39) 0.0003  0.24 (0.10 ; 0.39) 0.0012  
1st trimester 0.8 (1.1) 1.6 (1.0) 0.76 (0.36 ; 1.17) 0.0002 0.0111 0.80 (0.39 ; 1.21) 0.0001 0.0054 
2nd trimester 0.7 (1.0) 0.8 (1.1) 0.12 (-0.05 ; 0.29) 0.1587  0.09 (-0.10 ; 0.27) 0.3660  
3rd trimester 0.7 (1.0) 1.1 (1.3) 0.34 (0.07 ; 0.60) 0.0107  0.33 (0.06 ; 0.60) 0.0157  
A3 Having to avoid certain things, places or activities as anxiety-provoking? 
 0.2 (0.7) 1.0 (1.5) 0.83 (0.73 ; 0.93) <.0001  0.79 (0.68 ; 0.89) <.0001  
1st trimester 0.2 (0.7) 1.4 (1.8) 1.16 (0.87 ; 1.45) <.0001 <.0001 1.28 (1.00 ; 1.57) <.0001 <.0001 
2nd trimester 0.2 (0.7) 0.9 (1.4) 0.67 (0.54 ; 0.79) <.0001  0.54 (0.41 ; 0.67) <.0001  
3rd trimester 0.2 (0.6) 1.3 (1.6) 1.08 (0.89 ; 1.26) <.0001  1.09 (0.90 ; 1.28) <.0001  
A4 Incipient anxiety attacks (panic)? 
 0.1 (0.4) 0.2 (0.5) 0.05 (-0.01 ; 0.11) 0.0747  0.03 (-0.03 ; 0.09) 0.3127  
1st trimester 0.1 (0.4) 0.4 (0.6) 0.30 (0.13 ; 0.47) 0.0007 0.0097 0.35 (0.18 ; 0.52) <.0001 0.0005 
2nd trimester 0.1 (0.5) 0.2 (0.6) 0.04 (-0.04 ; 0.11) 0.3322  -0.02 (-0.09 ; 0.06) 0.7023  
3rd trimester 0.1 (0.4) 0.1 (0.3) -0.01 (-0.12 ; 0.10) 0.8807  -0.01 (-0.12 ; 0.11) 0.9432  
A5 Actual anxiety attacks? 
 0.0 (0.3) 0.1 (0.4) 0.02 (-0.01 ; 0.06) 0.2243  0.01 (-0.03 ; 0.04) 0.6966  
1st trimester 0.0 (0.3) 0.1 (0.3) 0.03 (-0.08 ; 0.13) 0.6088 0.8292 0.04 (-0.06 ; 0.15) 0.3917 0.7410 
2nd trimester 0.0 (0.2) 0.1 (0.4) 0.03 (-0.02 ; 0.07) 0.2061  0.00 (-0.05 ; 0.05) 0.9764  
3rd trimester 0.0 (0.3) 0.0 (0.3) 0.00 (-0.06 ; 0.07) 0.9108  0.00 (-0.06 ; 0.07) 0.8903  
A6 Recurrent, unpleasant compulsive thoughts that won’t stop? 
 0.1 (0.5) 0.2 (0.5) 0.02 (-0.04 ; 0.09) 0.5356  0.01 (-0.06 ; 0.08) 0.7621  
1st trimester 0.2 (0.5) 0.3 (0.7) 0.10 (-0.09 ; 0.29) 0.2912 0.3385 0.13 (-0.07 ; 0.32) 0.1964 0.1187 
2nd trimester 0.2 (0.5) 0.2 (0.5) -0.02 (-0.10 ; 0.07) 0.7136  -0.05 (-0.13 ; 0.04) 0.3020  
1 
 
3rd trimester 0.1 (0.4) 0.2 (0.5) 0.07 (-0.05 ; 0.20) 0.2561  0.08 (-0.05 ; 0.21) 0.2139  
A7 Having to check everything you do again and again? 
 0.1 (0.5) 0.1 (0.5) -0.01 (-0.08 ; 0.06) 0.7635  -0.01 (-0.08 ; 0.07) 0.8838  
1st trimester 0.1 (0.5) 0.1 (0.4) -0.02 (-0.21 ; 0.17) 0.8570 0.6018 -0.01 (-0.21 ; 0.19) 0.9170 0.6356 
2nd trimester 0.1 (0.5) 0.1 (0.4) -0.03 (-0.11 ; 0.05) 0.4539  -0.02 (-0.11 ; 0.07) 0.6613  
3rd trimester 0.1 (0.5) 0.2 (0.7) 0.04 (-0.08 ; 0.17) 0.4889  0.05 (-0.08 ; 0.19) 0.4097  
A8 Feeling very shy in company, for example when eating in front of other people? 
 0.2 (0.5) 0.1 (0.4) -0.10 (-0.17 ; -0.03) 0.0045  -0.10 (-0.18 ; -0.03) 0.0070  
1st trimester 0.2 (0.5) 0.1 (0.4) -0.10 (-0.30 ; 0.10) 0.3357 0.7860 -0.09 (-0.30 ; 0.11) 0.3733 0.7611 
2nd trimester 0.2 (0.5) 0.0 (0.3) -0.12 (-0.21 ; -0.03) 0.0081  -0.12 (-0.22 ; -0.03) 0.0112  
3rd trimester 0.2 (0.6) 0.1 (0.4) -0.06 (-0.20 ; 0.07) 0.3616  -0.06 (-0.20 ; 0.07) 0.3723  
A9 Had recurrent thoughts or memories of a very violent experience?  
 0.2 (0.6) 0.1 (0.5) -0.09 (-0.17 ; -0.00) 0.0411  -0.07 (-0.16 ; 0.02) 0.1331  
1st trimester 0.3 (0.7) 0.3 (0.8) 0.03 (-0.21 ; 0.27) 0.1930 0.5456 0.06 (-0.18 ; 0.31) 0.6204 0.4776 
2nd trimester 0.2 (0.6) 0.1 (0.3) -0.11 (-0.21 ; -0.01) 0.0343  -0.10 (-0.21 ; 0.01) 0.0774  
3rd trimester 0.2 (0.6) 0.1 (0.5) -0.08 (-0.23 ; 0.08) 0.3405  -0.05 (-0.21 ; 0.11) 0.5315  
A10 Difficulty performing your daily activities because of these symptoms? 
 0.2 (0.7) 0.2 (0.8) 0.03 (-0.05 ; 0.12) 0.4636  0.05 (-0.04 ; 0.14) 0.2973  
1st trimester 0.2 (0.7) 0.6 (1.3) 0.33 (0.07 ; 0.58) 0.0115 0.0301 0.38 (0.13 ; 0.64) 0.0033 0.0132 
2nd trimester 0.2 (0.7) 0.2 (0.7) -0.04 (-0.14 ; 0.07) 0.5196  -0.03 (-0.15 ; 0.08) 0.5758  
3rd trimester 0.1 (0.5) 0.2 (0.7) 0.07 (-0.09 ; 0.23) 0.4039  0.08 (-0.09 ; 0.24) 0.3763  
1p-value of a likelihood ratio test for difference in cohort effect between the three trimesters. 
 
